Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Israel Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20051
20062
20072
20083
20102
20113
20151
20161
20172
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status5
Withdrawn3
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beersheva Mental Health Center7
Janssen-Cilag International NV5
Alkermes, Inc.2
Eli Lilly and Company2
Sheba Medical Center2
Beer Yaakov - Ness Ziona Mental Health Center1
BeerYaakov Mental Health Center1
Dr. Inge Winter1
European Group for Research In Schizophrenia1
Janssen-Cilag Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia27
Psychotic Disorders11
Cognitive Dysfunction2
Bipolar Disorder1
Inflammation1
Major Depressive Disorder1
Neurobehavioral Manifestations1
Recurrence1
Tardive Dyskinesia1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.